Camarda Financial Advisors’s Medpace MEDP Stock Holding History

Camarda Financial Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-24	Closed	-$2K	–	301
2019 Q2	$2K	Hold	24	–	–	﹤0.01%	337
2019 Q1	$1K	Buy	+24	New	+$1.43K	﹤0.01%	473

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Camarda Financial Advisors's MEDP Position: Q3 2019 in Review

Camarda Financial Advisors sold out of Medpace (MEDP) in Q3 2019, closing a stake of 24 shares — an estimated $2K sold.

Camarda Financial Advisors first reported a position in MEDP in Q1 2019 and held it in 2 quarters. The position peaked at $2K in Q2 2019. 268 funds tracked by Wall St. Rank hold MEDP as of Q3 2019.

Camarda Financial Advisors reported no remaining Medpace position as of Q3 2019 after selling out during the quarter.
Camarda Financial Advisors sold 24 Medpace shares in Q3 2019, an estimated $2K.
Camarda Financial Advisors first reported a position in Medpace in Q1 2019 and held it in 2 quarters.
Camarda Financial Advisors's Medpace position peaked at $2K in Q2 2019.
268 funds tracked by Wall St. Rank held Medpace as of Q3 2019.

Based on Camarda Financial Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.